28530950|t|Effects of Buspirone on Agitation Associated With Dementia.
28530950|a|Ten patients with probable Alzheimer's disease participated in an open-label study of buspirone for agitation. The starting dose of 15 mg/day was increased by 5 mg every week until maximal improvement or 60 mg/day was reached. A significant decrease in agitation scores occurred at an average dose of 35 mg/day.
28530950	11	20	Buspirone	Chemical	MESH:D002065
28530950	24	33	Agitation	Disease	MESH:D011595
28530950	50	58	Dementia	Disease	MESH:D003704
28530950	64	72	patients	Species	9606
28530950	87	106	Alzheimer's disease	Disease	MESH:D000544
28530950	146	155	buspirone	Chemical	MESH:D002065
28530950	160	169	agitation	Disease	MESH:D011595
28530950	313	322	agitation	Disease	MESH:D011595
28530950	Negative_Correlation	MESH:D002065	MESH:D003704
28530950	Negative_Correlation	MESH:D002065	MESH:D000544
28530950	Negative_Correlation	MESH:D002065	MESH:D011595

